EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Gut Microbiome in Patients with Chronic Kidney Disease Stages 4 and 5: A Systematic Literature Review

Ioana Livia Suliman, Florin Gabriel Panculescu, Dragos Fasie, Bogdan Cimpineanu, Andreea Alexandru iD, Nelisa Gafar, Stere Popescu, Teodor Stefan Nitu, Florin-Daniel Enache, Tatiana Chisnoiu iD, Georgeta Camelia Cozaru iD, Liliana-Ana Tuta iD

International Journal of Molecular Sciences · 03.11.2025 · 26 (21) · 10706

DOI: 10.3390/ijms262110706 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.11.2025. Verfasst von Ioana Livia Suliman und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, "Ovidius" University of Constanta, 900470 Constanta, Romania. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This systematic review investigates the role of the gut microbiota in patients with advanced chronic kidney disease (CKD), specifically stages 4 and 5. Increasing evidence suggests that dysbiosis—an alteration in the normal balance of gut microbial populations—is not merely a secondary consequence of renal decline but a significant driver of disease progression. Such microbial imbalances are closely linked to a range of CKD-associated complications, including systemic inflammation, accumulation of uremic toxins, and heightened cardiovascular risk. Using PRISMA 2020 guidelines, we analyzed 87 peer-reviewed studies published between 2019 and 2025. The review revealed a consistent decline in beneficial microbes such as short-chain fatty acid-producing bacteria were markedly reduced, while populations of uremic toxin-generating microbes were notably increased. This microbial imbalance was associated with elevated concentrations of indoxyl sulfate and p-cresyl sulfate, heightened systemic inflammation, and impaired intestinal barrier integrity. Five conceptual frameworks—including the gut—kidney axis and endotoxemia—inflammation loop—were discussed. Ten microbiome assessment tools were reviewed, including 16S rRNA sequencing and LC-MS/MS for uremic toxin detection. Although probiotics, prebiotics, and synbiotics are gaining attention as potential therapeutic options, questions remain regarding their long-term efficacy and incorporation into standard clinical practice. Increasing scientific evidence underscores the gut microbiome’s pivotal role in CKD progression and management, reinforcing the need for carefully designed, long-term interventions aimed at restoring a healthier microbial balance to support renal function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeRenal Insufficiency, ChronicHumansDisease ProgressionDysbiosisInflammationUremic Toxins

Stichwörter der Autor:innen

chronic kidney diseasedysbiosisgut microbiota

Substanzen

Uremic Toxins

Autor:innen und Institutionen

  • Faculty of Medicine, "Ovidius" University of Constanta, 900470 Constanta, Romania.
  • "Sfantul Apostol Andrei" Emergency County Clinical Hospital, 900591 Constanta, Romania.
  • Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology (CEDMOG), "Ovidius" University of Constanta, 900591 Constanta, Romania.

ORCID-Profile: Andreea Alexandru, Tatiana Chisnoiu, Georgeta Camelia Cozaru, Liliana-Ana Tuta

Zitieren

APA

Suliman, I. L., Panculescu, F. G., Fasie, D., Cimpineanu, B., Alexandru, A., Gafar, N., Popescu, S., Nitu, T. S., Enache, F. D., Chisnoiu, T., Cozaru, G. C., & Tuta, L. A. (2025). Gut Microbiome in Patients with Chronic Kidney Disease Stages 4 and 5: A Systematic Literature Review. International Journal of Molecular Sciences, 26(21), 10706. https://doi.org/10.3390/ijms262110706

Vancouver

Suliman IL, Panculescu FG, Fasie D, Cimpineanu B, Alexandru A, Gafar N, et al. Gut Microbiome in Patients with Chronic Kidney Disease Stages 4 and 5: A Systematic Literature Review. International Journal of Molecular Sciences. 2025;26(21):10706. doi:10.3390/ijms262110706

BibTeX
@article{Suliman2025,
  author = {Suliman, Ioana Livia and Panculescu, Florin Gabriel and Fasie, Dragos and Cimpineanu, Bogdan and Alexandru, Andreea and Gafar, Nelisa and Popescu, Stere and Nitu, Teodor Stefan and Enache, Florin-Daniel and Chisnoiu, Tatiana and Cozaru, Georgeta Camelia and Tuta, Liliana-Ana},
  title = {Gut Microbiome in Patients with Chronic Kidney Disease Stages 4 and 5: A Systematic Literature Review},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10706},
  doi = {10.3390/ijms262110706}
}
Kostenlos starten →